medigraphic.com

2011, Número 2

<< Anterior Siguiente >>

Rev Med MD 2011; 2.3 (2)


Manejo de hipertensión intracraneal en criptococosis meníngea en SIDA

Amador-Lara F

Idioma: Español
Referencias bibliográficas: 19
Paginas: 72-77
Archivo PDF: 577.25 Kb.


RESUMEN

La Criptococosis meníngea es la causa más frecuente de meningitis en pacientes con Síndrome de Inmunodeficiencia Adquirida (SIDA). El agente causal es el hongo encapsulado Cryptococcus neoformans. La clínica típica involucra cefalea intensa holocraneal sin predominio de horario o posición, síndrome de cráneo hipertensivo, fotofobia y en casos severos, crisis convulsivas y alteración del estado de alerta. El tratamiento de primera línea se basa en el esquema Anfotericina B + Flucitosina, logrando la supresión del microorganismo. Este tipo de meningitis puede causar alteración en la reabsorción de líquido cefalorraquídeo (LCR), que secundariamente puede ocasionar datos de cráneo hipertensivo.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Van der Horst CM, Saag MS, Cloud GA, et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. N Engl J Med 1997; 337:15–21.

  2. Majumder S, Mandal SK, Bandyopadhyay D. Prognostic Markers in AIDSrelated Cryptococcal Meningitis. JAPI 2011; 59:152-154.

  3. Bicanic T, Brouwer AE, Meintjes G, et al. Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures. AIDS 2009; 23:701–706.

  4. Loyse A, Wainwright H, Jarvis JN, Bicanic T, Rebe K, Meintjes G, Harrison TS. Histopathology of the arachnoid granulations and brain in HIVassociated cryptococcal meningitis: correlation with cerebrospinal fluid pressure. AIDS 2010; 24:405–410.

  5. Gambarin KJ, Hamill RJ. Management of Increased Intracranial Pressure in Cryptococcal Meningitis. Curr Infect Dis Rep 2002; 4:332–338.

  6. Graybill JR, Sobel J, Saag M, van Der Horst C, Powderly W, Cloud G, et al. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups. Clin Infect Dis 2000; 30:47–54.

  7. Newton PN, Thai le H, Tip NQ, et al. A randomized, double-blind, placebo-controlled trial of acetazolamide for the treatment of elevated intracranial pressure in cryptococcal meningitis. Clin Infect Dis 2002; 35:769–772.

  8. Hsin-Yun Sun, Chien-Ching Hung, Shan-Chwen Chang. Management of Cryptococcal Meningitis with Extremely High Intracranial Pressure in HIVInfected Patients. Clin Infect Dis 2004; 38:1790–2

  9. Antinori S, Ridolfo AL, Gianelli E, et al. The role of lumbar puncture in the management of elevated intracranial pressure in patients with AIDSassociated cryptococcal meningitis. Clin Infect Dis 2000; 31:1309–10.

  10. Macsween KF, Bicanic T, Brouwer AE, Marsh H, Macallan DC, Harrison TS. Lumbar drainage for control of raised cerebrospinal fluid pressure in cryptococcal meningitis: case report and review. J Infect. 2005 Nov; 51(4):e221-4.

  11. Fessler RD, Sobel J, Guyot L, Crane L, Vazquez J, Szuba MJ, Diaz FG. Management of elevated intracranial pressure in patients with Cryptococcal meningitis. J Acquir Immune Defic Syndr Hum Retrovirol 1998 Feb 1; 17(2):137-42.

  12. Macsween KF, Bicanic T, Brouwer AE, Marsh H, Macallan DC, Harrison TS. Lumbar drainage for control of raised cerebrospinal fluid pressure in cryptococcal meningitis: case report and review. J Infect 2005; 51:e221-4.

  13. Coplin WM, Avellino AM, Kim DK, Winn HR, Grady MS. Bacterial meningitis associated with lumbar drains: a retrospective cohort study. J Neurol Neurosurg Psychiatry 1999; 67:468–473.

  14. Park MK, Hospenthal DR, Bennett JE. Treatment of hydrocephalus secondary to cryptococcal meningitis by use of shunting. Clin Infect Dis 1999; 28:629–633.

  15. Liliang PCH, Liang ChL, Chang WN, Lu K, Lu ChL. Use of Ventriculoperitoneal Shunts to Treat Uncontrollable Intracranial Hypertension in Patients Who Have Cryptococcal Meningitis without Hydrocephalus. Clin Infect Dis 2002; 34:e64–8.

  16. Woodworth GF, McGirt MJ, Williams MA, et al. The use of ventriculoperitoneal shunts for uncontrollable intracranial hypertension without ventriculomegally secondary to HIV-associated cryptococcal meningitis. Surg Neurol 2005; 63:529–531; discussion 531–532.

  17. Bach MC, Tally PW, Godofsky EW. Use of cerebrospinal fluid shunts in patients having acquired immunodeficiency syndrome with cryptococcal meningitis and uncontrollable intracranial hypertension. Neurosurgery 1997; 41:1280–3.

  18. Calvo A, Hernández P, Spagnuolo E, Johnston E. Surgical treatment of intracranial hypertension in encephalic cryptococcosis. Br J Neurosurg 2003 Oct; 17(5):450-5.

  19. John R. Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, Harrison TS, Larsen RA, Lortholary O, Nguyen MH, Pappas PG, Powderly WG, Singh N, Sobel JD, Sorrell TS. Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America. Clin Infect Dis 2010; 50:291–322.




2020     |     www.medigraphic.com